Comprehensive Pancreatic Cancer Treatment for Patients Traveling From Miami, FL
If you’re thinking about traveling from the Miami, FL, area to receive pancreatic cancer treatment at Moffitt Cancer Center in Tampa, you may be interested to know that studies have proven that patients who travel to a high-volume academic medical center for gastrointestinal cancer treatment have better survival and quality-of-life outcomes.
One reason is that a patient who receives pancreatic cancer treatment at a specialty cancer center is more likely to undergo lymph node dissection, which is the current standard of care for pancreatic cancers that can be removed surgically. This procedure involves the removal of selected lymph nodes so that these glands can be examined under a microscope for evidence of cancer.
In addition to having access to leading-edge therapies, there are many other reasons to travel from Miami, Florida, to Moffitt to receive pancreatic cancer treatment in our Gastrointestinal Oncology Program. Consider that:
- We take a multispecialty approach to treatment, ensuring that each patient receives several expert opinions (and the resulting peace of mind) in a single location.
- We are the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, which is a testament to our groundbreaking research.
- We maintain a robust portfolio of clinical trials, allowing our patients to benefit from promising new treatments as soon as they become available.
Many patients travel from Miami, FL, and elsewhere to receive world-class pancreatic cancer treatment at Moffitt. If you’d like to make the trip but aren’t sure where to stay, our supportive care specialists can recommend local accommodations for you and your family. We’ve partnered with several nearby hotels that are committed to upholding the high standards we mandate for our patients.
To learn more or request an appointment at Moffitt Cancer Center, call 1-888-663-3488 or complete a new patient registration form online. We do not require referrals.
Pancreatic Cancer
- Adrenal Cancer
- Anal Cancer
- Appendiceal (Appendix) Cancer
- Astrocytoma
- Basal Cell Carcinoma
- Bladder Cancer
- Bone Metastasis
- Brain Cancer
- Brain Tumor
- Breast Cancer
- Cervical Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Colon Cancer
- Colorectal Cancer
- Cutaneous T-Cell Lymphoma
- Ductal Carcinoma In Situ
- Endometrial (Uterine) Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Gastrointestinal Carcinoid Tumor
- GIST (Gastrointestinal Stromal Tumor)
- Glioblastoma
- Head and Neck Cancer
- HER2 Positive Breast Cancer
- Hodgkin Lymphoma
- Inflammatory Breast Cancer
- Invasive Ductal Carcinoma
- Kidney (Renal Cell) Cancer
- Leukemia
- Liver (Hepatocellular) Cancer
- Low-Grade Glioma
-
Lung Cancer
- Signs and Symptoms
- Diagnosis
- Treatment
- FAQs
- Lung Cancer Early Detection Center
- Lung Cancer Screening and Surveillance Program
- Lung Nodules
- Lung Surveillance Clinic
- Metastatic Lung Cancer
- Recurrence
- Survival Rate
- Your Lung Cancer Specialists
- Lung and Thoracic Tumor Education (LATTE)
- Thoracic Clinic Updates
- Insurance & Financial Information
- Lymphomas (Hodgkin and Non-Hodgkin)
- Melanoma
- Meningioma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Breast Cancer
- Multiple Myeloma-Plasma Cell Tumor
- Myelodysplastic Syndromes (MDS)
- Neuroendocrine Tumor
- Neurofibromatosis
- Non-Hodgkin Lymphoma
- Oral Cavity (Mouth) Cancer
- Oral Cavity or Throat Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancoast Tumor
- Pancreatic Cancer
- Penile Cancer
- Pituitary Adenoma
- Prostate Cancer
- Rectal Cancer
- Sarcoma
- Skin Cancer (Nonmelanoma)
- Skull Base Tumors
- Small Intestine Cancer
- Spinal Tumor
- Squamous Cell Carcinoma
- Stomach (Gastric) Cancer
- Testicular Cancer
- Throat Cancer
- Thymoma
- Thyroid Cancer
- Tongue Cancer
- Tracheal Cancer
- Triple Negative Breast Cancer
- Vaginal Cancer
- Vulvar Cancer